Former Chief Commercial Officer · AGIOS PHARMACEUTICALS, INC. (AGIO)

Darrin Miles

FY2021 is the first fiscal year CompBrief holds for Darrin Miles as a named executive officer of AGIOS PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,473,768

Salary $444,206Stock awards $623,480

5th of 7 named executive officers at Agios Pharmaceuticals by FY2021 total.

7 named officers on file for AGIOS PHARMACEUTICALS, FY2021

Darrin Miles’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • AGIO’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AGIOS PHARMACEUTICALS’s whole pay program stands against its peers

  • AGIOS PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AGIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Darrin Miles’s full pay file as a PDF — free

More than this page: up to 10 years of Darrin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Darrin Miles compensation by year

AGIOS PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as AGIOS PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$444,206
Bonus$0
Stock awards$623,480
Option awards$1,404,373
Non-equity incentive$0
Pension and deferred compensation$0
All other$1,709
Total$2,473,768

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AGIOS PHARMACEUTICALS, INC. DEF 14A filed April 28, 2022, accession 0001193125-22-127495, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AGIOS PHARMACEUTICALS, INC. filed document, accession 0001193125-22-127495. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

AGIOS PHARMACEUTICALS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jacqualyn FouseFormer Chief Executive Officer$6,519,427
Jonathan BillerFormer Chief Financial Officer, Head of Corporate Affairs$2,832,035
Bruce CarFormer Chief Scientific Officer$2,803,973
Christopher BowdenFormer Chief Medical Officer$2,774,889
Darrin Miles · this pageFormer Chief Commercial Officer$2,473,768
Sarah GheuensChief Medical Officer$1,169,510
Richa PoddarFormer Chief Commercial Officer$1,074,744

The full AGIOS PHARMACEUTICALS compensation record

free company brief

This page is one person within AGIOS PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AGIOS PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Darrin Miles's compensation dossier · One-time report. No refunds.